By Deron Hamel Attending Summerfest Camp for the past four years has been a benefit to both 15-year-old Jack Moller and his parents, says Jack’s dad, Tim. For Jack, Summerfest Camp has been an opportunity to become more independent; for his parents, the two-week camp has provided a venue where they feel comfortable letting Jack…
By Deron Hamel Whether you’re someone who loves a good mystery or you just like to have fun, you don’t want to miss a fundraising gala hosted by Epilepsy Ontario and EpLink on Oct. 20. The event, called the Shaken, Not Stirred gala, will be held in Toronto and will feature a James Bond theme…
By Deron Hamel The Ontario government is asking for input from people who have had experience living with uncontrolled focal onset seizures for an upcoming assessment of a new anti-seizure drug. An expert committee, established by the province to review medications, will assess this input along with clinical trial data and an economic evaluation of…
By Deron Hamel Epilepsy Ontario is urging people taking 250-mg soft-gel capsules of the anti-seizure medication Zarontin (ethosuximide) to closely scrutinize their capsules to ensure they are not defective, following a warning issued by Erfa Canada 2012 Inc. and Health Canada. Erfa Canada 2012 Inc., the company that manufactures Zarontin, and Health Canada have received…
Sponsor Image 1
Sponsor Image 2
Sponsor Image 3
Sponsor Image 1
Sponsor Image 2
